DRUG COVERAGE: MMA Steps Up Screening Test Coverage

Why This Topic Matters

The topic affects whether cardiovascular screening tests are reported in a way that aligns with Medicare coverage expectations, which can impact reimbursement and claim acceptance. It is relevant for practices that perform preventive laboratory screening and want to understand the broad Medicare billing context described in the article.

Article Sections

1. Medicare coverage for cardiovascular screening tests

   Introduces the cardiovascular screening benefit under the Medicare Modernization Act and explains the general population the coverage is intended to address.

2. Screening diagnosis codes and linked procedure codes

   Summarizes the screening-related diagnosis code set and the associated laboratory procedure code set discussed in the article.

3. Lipid panel exception and billing frequency limits

   Describes the special grouping discussion for lipid testing and the article’s broad timing and ordering considerations for covered screening.